TRAK1 and neoplasm: We speculated whether alternative splicing rather than alternative TSS could explain the observed findings for TRAK1. However, in both normal and tumor samples only one qRT-PCR product was observed for the primer set spanning the alternative TRAK1 exon 1B (from exon 2 to 3), with a length consistent with lack of exon 1B.